The global bioreactors and fermenters market size is expected to reach USD 7.04 Billion by 2030 at a CAGR of 10.0% through the forecast period, according to the latest report by Reports and Data. Increasing popularity of single-use bioreactor among biopharmaceutical companies to cultivate biologics is the key factor expected to drive market revenue growth over the forecast period.
Bioreactors and fermentors are culture systems to produce organisms or cells. They are used in various applications, including the manufacturing of biopharmaceuticals, basic research development, chemicals, food food additives, and other products. Cultivating cells and microbes in bioreactors can save work, time, and lab-space. It also improves the reproducibility and efficiency of cell growth and product formation.
Increasing focus of biologics manufacturers to scale-up production technologies for biologics is expected to stimulate global bioreactors and fermenters market trends. Moreover, surging demand for personalized medicines coupled with rising number of FDA approved orphan drugs has led to increased bio production, which in turn is expected to offer major opportunities for the industry growth in the coming years.
Market Dynamics:
The pharma and healthcare sector has significantly advanced in the recent years and is expected to register steady revenue growth over the forecast period owing to rapid innovations in medical technology, increasing investments, rising healthcare expenditure and high adoption of advanced products and systems. Factors such as rising prevalence of chronic diseases such as diabetes, cancer, cardiovascular diseases, and neurological disorders across the globe, rising cases of coronavirus, improving healthcare infrastructure and research facilities, and increasing adoption of remote patient monitoring services and home care settings are expected to fuel global market revenue growth over the forecast period. In addition, increasing number of hospitals and ambulatory care centers worldwide, high demand for personalized medicine, increasing investments in drug discovery and growing investments by public and private sectors are expected to drive global market growth in the coming years.
Get a sample of the report @ https://www.reportsanddata.com/sample-enquiry-form/285
Leading companies operating in the market are:
Sartorius AG BBI, GE Healthcare, Praj Hipurity Systems, Danaher (Pall), ZETA, Thermo Fisher, Pierre Guerin (DCI-Biolafitte), Bioengineering AG, Merck KGaA, Solaris, Applikon Biotechnology, Eppendorf AG, and Infors HT among others. Rising investments by the key industry players for the RD activities will bolster market growth over the analysis period.
Competitive Landscape:
The report also focuses on details of each market player including its global position, financial standing, revenue generation, company overview, product service portfolio. The Bioreactors and Fermenters market is extremely competitive and consists of several key players at regional and global level. Key players are focused on adopting various strategies such as new product launches, mergers and acquisitions, investments in RD, partnerships, joint ventures and collaborations to strengthen their market position and enhance product portfolio.
To know more about the report @ https://www.reportsanddata.com/report-detail/bioreactors-and-fermenters-market
The report also offers detailed insights about market segmentation based on type, application and regional bifurcation:
Bioreactors and Fermenters Market Segmentation:
Type Outlook (Revenue, USD Billion; 2019-2030)
- Single-use Bioreactors
- Multiple-use Bioreactors
Application Outlook (Revenue, USD Billion; 2019-2030)
- Biopharmaceutical Companies
- CROs
- Academic and Research Institutes
- Others
Download Summary @ https://www.reportsanddata.com/download-summary-form/285
Regional Outlook:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East Africa
Request a customization of the report @ https://www.reportsanddata.com/request-customization-form/285
About Reports and Data
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
Contact Us:
John W
Head of Business Development
Reports And Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
E-mail: sales@reportsanddata.com
LinkedIn | Twitter | Blogs
Read More Related Reports:
Antifungal Drugs Market @ https://www.biospace.com/article/antifungal-drugs-market-size-to-reach-usd-13-39-billion-in-2028-says-reports-and-data/
DNA Sequencing Market @ https://www.biospace.com/article/dna-sequencing-market-size-to-reach-usd-12-55-billion-in-2028-says-reports-and-data/
Testosterone Replacement Therapy Market @ https://www.biospace.com/article/testosterone-replacement-therapy-market/
Occlusion Devices Market @ https://www.biospace.com/article/occlusion-devices-market-revenue-growth-driven-by-technological-advances-in-surgical-equipment-reports-and-data-/
Deep Brain Stimulation Devices Market @ https://www.biospace.com/article/deep-brain-stimulation-devices-market-revenue-growth-driven-by-continuous-advancements-in-neuroimaging-technologies-reports-and-data-/
